Improving treatment choices for women with advanced ovarian cancer
Improving Treatment Selection in Advanced Ovarian Cancer
This study is looking to improve treatment options and survival for women with advanced ovarian cancer by creating a personalized approach that takes into account each patient's unique situation and tumor details, so they can receive the best possible care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project ID | NIH-11031293 on NIH RePORTER |
What this research studies
This research aims to enhance treatment selection and survival rates for women diagnosed with advanced ovarian cancer. It focuses on developing a simulation modeling framework that will help identify personalized treatment strategies based on individual patient characteristics and tumor mutations. By analyzing the effectiveness of various treatment sequences, including surgery and chemotherapy, the research seeks to optimize outcomes while minimizing costs and toxicities associated with current therapies. Patients will benefit from tailored treatment plans that consider their unique medical profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with advanced ovarian cancer who are considering treatment options.
Not a fit: Patients with early-stage ovarian cancer or those who have already received extensive treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved survival rates and better quality of life for women with advanced ovarian cancer through personalized treatment strategies.
How similar studies have performed: Previous research has shown promise in using personalized treatment approaches for cancer, indicating that this methodology could yield significant advancements in care.
Where this research is happening
Columbus, UNITED STATES
- Ohio State University — Columbus, United States (Active)
Researchers
- Principal investigator: Pandharipande, Pari Vijay — Ohio State University
- Study coordinator: Pandharipande, Pari Vijay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.